CELL2B
Cell2B is a biotechnology company that develops advanced cellular therapies for its patients. Its aim is to deliver a set of therapies to patients and caregivers to tackle immune, inflammatory, and oncological malignancies. Cell2B develops new proprietary techniques and protocols to increase their numbers and effectiveness in tissue and organ regeneration. Founded in 2011, it is headquartered in Cantanhede, Coimbra.
CELL2B
Industry:
Biotechnology Health Care
Founded:
2011-01-01
Address:
Cantanhede, Coimbra, Portugal
Country:
Portugal
Website Url:
http://www.cell2b.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
0
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Wordpress Plugins Global Site Tag
Similar Organizations
Affini-T Therapeutics
Affini-T Therapeutics is a biotechnology company developing T-cell therapies for patients suffering from cancer.
Beren Therapeutics
Beren Therapeutics is a biotechnology company that develops innovative therapies to make them accessible to every patient.
Edvince
Edvince is a biotechnology company that develops a new treatment.
Enzyvant Sciences
Enzyvant Sciences is a biotechnology company which focuses on developing treatments for rare diseases.
Investors List
ChangePartners
ChangePartners investment in Venture Round - Cell2B
More informations about "Cell2B"
Cell2B - Crunchbase Company Profile & Funding
Cell2B is a biotechnology company that develops advanced cellular therapies for its patients. Its aim is to deliver a set of therapies to patients and caregivers to tackle immune, inflammatory, โฆSee details»
Cell2B - Funding, Financials, Valuation & Investors - Crunchbase
Nov 19, 2013 Cell2B is a biotechnology company that develops advanced cellular therapies for its patients. Search Crunchbase. Start Free Trial . Chrome Extension. Solutions. Products. ...See details»
Cell2B Company Profile | Management and Employees List
Cell2B is a biotechnology company dedicated to the development of advanced cellular therapies. Our goal is to deliver a new set of therapies to patients and caregivers to tackle immune, โฆSee details»
Cell2B Company Profile 2024: Valuation, Funding & Investors
Cell2B General Information Description. Developer of a cell therapy intended to prevent and treat organ rejection. The company's therapy targets acute Graft-versus-Host-Disease (GvHD), a โฆSee details»
Cell2B Information - RocketReach
Cell2B is a biotechnology company dedicated to the development of a new line of healthcare therapies to prevent and treat organ rejection in patients undergoing organ or tissue โฆSee details»
Interview: David Malta and Daniela Couto, Co-Founders, Cell2B, โฆ
Jul 30, 2014 What makes Cell2B the partner of choice among all the cell-based therapy companies in Portugal? DM: Cell2B is the most developed company, and the only one ready โฆSee details»
Cell2B - VentureRadar
Similar Companies: InnDura Therapeutics USA n/a InnDura Therapeutics is developing breakthrough NK cell therapies that change lives. InnDura's platform is based on licensed โฆSee details»
Biotech of the week: Cell2b, Promising Portugese Cell Therapy
Oct 2, 2015 ImmuneSafe works by modulating the immune and inflammatory responses and promoting tissue regeneration. Cell2B hope it will able to treat other immunological and โฆSee details»
Cell2B - Advanced Therapeutics SA - Drug pipelines, Patents, โฆ
Explore Cell2B - Advanced Therapeutics SA with its drug pipeline, therapeutic area, technology platform, .See details»
Cell2B - Crunchbase
Cell2B is a biotechnology company that develops advanced cellular therapies for its patients.See details»
Cell2B - Overview, News & Similar companies | ZoomInfo.com
Cell2B is a biotechnology company dedicated to the development of advanced cellular therapies. Our goal is to deliver a new set of therapies to pat ients and caregivers to tackle immune, โฆSee details»
โ๏ธCell2B - Advanced Therapeutics โ Consulting Organization โฆ
Oct 11, 2024 Cell2B - Advanced Therapeutics โ Consulting Organization from Portugal, has experience with Horizon 2020 (2014 - 2020), it`s involved in Laboratory & Measurement, โฆSee details»
Cell2B - Advanced Therapeutics - F6S
Cell2B is a developer of cell therapies for immune and inflammatory diseases. It was incorporated in 2011 with technology developed by its founders and licensed from the MIT in Boston and โฆSee details»
Orphanet: Cell2B Advanced Therapeutics SA
Cell2B Advanced Therapeutics SA. Biocant Park Parque, Tecnológico de Cantanhede, Nucleo 4, Lote 4A. 3060 197 CANTANHEDE . PORTUGAL. Phone 1: 351 211 211 157 Contact email: โฆSee details»
Cell2B, pushing boundaries in cell therapy - Portugal Startups
Nov 25, 2014 Cell2B, a biotechnology company, has one goal: to deliver a new set of cell therapies to people who tackle immune and inflammatory malignancies. The company with a โฆSee details»
The winner of the Bluepharma/a2b has been announced
The winner was Cell2B, a technology-based company that develops solutions for human organ rejection. The company was founded in 2011 and its goal is to provide a new generation of โฆSee details»
Cell2B - Tech Stack, Apps, Patents & Trademarks - Crunchbase
Cell2B uses 10 technology products and services including HTML5, Google Tag Manager, and jQuery, according to G2 Stack. Cell2B is actively using 5 technologies for its website, โฆSee details»
EU/3/14/1388 - European Medicines Agency
Cell2B Advanced Therapeutics, SA Biocant Park Núcleo 4, Lote 4A 3060-197, Cantanhede Portugal Tel. +351 211 211 157 E-mail: [email protected]. Review of designation. The โฆSee details»
EU/3/13/1129 - orphan designation for treatment of graft-versus โฆ
On 7 June 2013, orphan designation (EU/3/13/1129) was granted by the European Commission to Cell2B Advanced Therapeutics, SA, Portugal, for allogeneic bone-marrow-derived โฆSee details»
Visual & Audible Warning Systems - Cell2
Our focus is on quality, outstanding service and JIT (Just in Time) delivery to customers. In the last decade, Cell2 has expanded internationally and now operates from two locations; Vigo โฆSee details»